James Engelhart
Overview
James Engelhart received an average of $2M in total compensation, including $334K in salary, at Biohaven Pharmaceutical Holding Co Ltd. from 2016 to 2019.
Source: SEC filings on March 20, 2020, April 11, 2019, and March 29, 2018.
Related executives
We found six more executives who work or worked at Biohaven Pharmaceutical Holding Co Ltd..
Vlad Coric
Biohaven Pharmaceutical Holding Co Ltd.
Chief Executive Officer
William Jones
Biohaven Pharmaceutical Holding Co Ltd.
Chief Commercial Officer of Migraine & Common Diseases
Kimberly Gentile
Biohaven Pharmaceutical Holding Co Ltd.
Senior Vice President, Clinical Operations
Elyse Stock
Biohaven Pharmaceutical Holding Co Ltd.
Chief Medical Officer
Charles Conway
Biohaven Pharmaceutical Holding Co Ltd.
Chief Scientific Officer
John Tilton
Biohaven Pharmaceutical Holding Co Ltd.